The abstract submission portal is now closed. All submitting authors will be notified of their acceptance by March 30, 2019.
The HHT International Scientific Conference is hosted and sponsored by Cure HHT. The Conference Organizing Committee invites authors to submit abstracts to be considered for inclusion in the Scientific Program for either oral or poster presentations.
The conference sessions will be organized around the themes of Mechanism, Diagnosis, Treatment, Genetics, Drug Discovery, and Epidemiology, however, other topics of research are encouraged and welcomed for submission. Within each of these themes we will bring together basic scientists and clinicians, in the hope of stimulating and educating both.
Abstracts should only include original data. Case reports must be submitted for poster presentation.
If you have any problems with the abstract submission process, please contact Nicole Schaefer at email@example.com.
Outstanding Oral Presentation and Poster Awards will be presented to Residents, Postdoctoral/Clinical Fellows, PhD Candidates or Early Stage Investigators for outstanding presentation of their abstracts. Awardees are selected on site and award recipients were announced during the last session on Sunday, June 11, 2017. These awards include a certificate and monetary award of $250.00 (US).
Cure HHT was honored to provide prizes for the best young scholar presentations. Congratulations to our winners!
Anthony Cannavicci, BSC, University of Toronto / St. Michael’s Hospital
Utility Of HHT Patient Specific Gene Mutations To Link Families In Databases
Daniel DePietro, MD, University of Pennsylvania
Can Graded Contrast Echocardiography Be Used For Post-Treatment Surveillance Of Pulmonary Arteriovenous Malformations?
Melissa Hector-Greene, PhD, Duke University
Role Of Type III Transforming Growth Factor-Β Receptor In Regulating ALK1 Signaling And Endothelial Biology
Anna Hosman, MD, PhD, St. Antonius Hospital
Age Related Sensitivity And Specificity Of The Curacao Criteria
Sara Plumitallo, PhD, University of Pavia
Circulating Micrornas In Hereditary Hemorrhagic Telangiectasia: Preliminary Results Identify Significant Differences Among Patients
Elisa Rossi, PhD, Université Paris Descartes
Human Endoglin As A Potential New Partner Involved In Platelet-Endothelium Interactions
Ali Tayebi-Meybodi, MD, University of California San Francisco
Surgical Treatment Versus Non-Surgical Treatment For Brain Arteriovenous Malformations In Patients With Hereditary Hemorrhagic Telangiectasia: A Retrospective Multicenter Consortium Study
Whitney Wooderchak-Donahue, PhD, University of Utah / ARUP Laboratory
Identification Of New Genes And Genetic Modifiers In HHT That Alter Clinical Severity
Up to eight awards will be given in these categories: